Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
48
NMPA:48
Drug Approvals
Sildenafil Citrate Orodispersible Tablets
- Product Name
- 枸橼酸西地那非口崩片
- Approval Number
- 国药准字H20249739
- Approval Date
- Dec 17, 2024
NMPA
Cefprozil for Suspension
- Product Name
- 头孢丙烯干混悬剂
- Approval Number
- 国药准字H20243606
- Approval Date
- Jul 23, 2024
NMPA
Cefprozil for Suspension
- Product Name
- 头孢丙烯干混悬剂
- Approval Number
- 国药准字H20243605
- Approval Date
- Apr 24, 2024
NMPA
Tropisetron Hydrochloride Tablets
- Product Name
- 盐酸托烷司琼片
- Approval Number
- 国药准字H20148002
- Approval Date
- Mar 26, 2024
NMPA
Loxoprofen Sodium Capsules
- Product Name
- 洛索洛芬钠胶囊
- Approval Number
- 国药准字H20148001
- Approval Date
- Mar 26, 2024
NMPA
Cefixime Dispersible Tablets
- Product Name
- 头孢克肟分散片
- Approval Number
- 国药准字H20123122
- Approval Date
- Mar 26, 2024
NMPA
Cefixime Dispersible Tablets
- Product Name
- 头孢克肟分散片
- Approval Number
- 国药准字H20123123
- Approval Date
- Mar 15, 2024
NMPA
Ceftazidime for Injection
- Product Name
- 注射用头孢他啶
- Approval Number
- 国药准字H20093633
- Approval Date
- Mar 15, 2024
NMPA
Ceftazidime for Injection
- Product Name
- 注射用头孢他啶
- Approval Number
- 国药准字H20093635
- Approval Date
- Mar 15, 2024
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- Next
Clinical Trials
No trials found
News
No news found